Cargando…
Accumulation and therapeutic modulation of 6-sulfo LacNAc(+) dendritic cells in multiple sclerosis
OBJECTIVE: To examine the potential role of 6-sulfo LacNAc(+) (slan) dendritic cells (DCs) displaying pronounced proinflammatory properties in the pathogenesis of multiple sclerosis (MS). METHODS: We determined the presence of slanDCs in demyelinated brain lesions and CSF samples of patients with MS...
Autores principales: | Thomas, Katja, Dietze, Kristin, Wehner, Rebekka, Metz, Imke, Tumani, Hayrettin, Schultheiß, Thorsten, Günther, Claudia, Schäkel, Knut, Reichmann, Heinz, Brück, Wolfgang, Schmitz, Marc, Ziemssen, Tjalf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4204231/ https://www.ncbi.nlm.nih.gov/pubmed/25340085 http://dx.doi.org/10.1212/NXI.0000000000000033 |
Ejemplares similares
-
Current Concepts on 6-sulfo LacNAc Expressing Monocytes (slanMo)
por: Ahmad, Fareed, et al.
Publicado: (2019) -
Phenotype, Function, and Mobilization of 6-Sulfo LacNAc-Expressing Monocytes in Atopic Dermatitis
por: Baran, Wojciech, et al.
Publicado: (2018) -
Neoadjuvant Radiochemotherapy Significantly Alters the Phenotype of Plasmacytoid Dendritic Cells and 6-Sulfo LacNAc(+) Monocytes in Rectal Cancer
por: Wagner, Felix, et al.
Publicado: (2019) -
6-Sulfo LacNAc (Slan) as a Marker for Non-classical Monocytes
por: Hofer, Thomas P., et al.
Publicado: (2019) -
A Novel Modular Antigen Delivery System for Immuno Targeting of Human 6-sulfo LacNAc-Positive Blood Dendritic Cells (SlanDCs)
por: Bippes, Claudia C., et al.
Publicado: (2011)